LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Science
• Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

patients, galunisertib, part, psmad, study, glioma, article, cohort, cycles, pubmed, google, scholar, cas, mgday, treatment, panel, cell, clinical, cells, plasma, baseline, cancer, tgfβ, tumor, dose, expression, growth, levels, benefit, idh, received, glioblastoma, fig, lomustine, table, observed, inhibition, treated, receptor, inhibitor, signaling, bid, samples, results, tissue, response, day, transforming, combination, assessed,

Topics {✒️}

tgf-beta signalling-related markers full size image nonenzyme-inducing anti-epileptic drugs eiae enzyme-inducing anti-epileptic enzyme-inducing anti-epileptic drugs targeted therapy cd4+cd25+cd127−/lofoxp3+ cells epidermal growth factor monitoring anti-tgfbetar therapy article download pdf specific receptor tgf-βri observed tgf-β-stimulated psmad2 heteroaryl-substituted pyrazole inhibitors cd4+cd25+ cd127−/lofoxp3+ tgf-beta2-dependent regulation tgf-beta receptor proton pump inhibitors profound long-lasting depletion ipilimumab-induced severe enterocolitis enzyme-inducing antiepileptic drugs making tgf-β signaling johns hopkins university tgf-β-stimulated tsmad2 [ promote epithelial-mesenchymal transition pre-existing medical conditions cytotoxic t-lymphocyte antigen-4 minimum post-baseline values oligonucleotide-based microarray analysis tgf-beta signaling multi-analyte immunoassay panel standard temozolomide-based radiochemotherapy refractory/relapsed malignant glioma tgf-beta2 inhibitor trabedersen patients receiving enzyme-inducing integrated genomic analysis tgf-β inhibitors [10] small molecule inhibitors full access minimum post-dose psmad2 glioma-initiating cell population anti-tumor activity luis paz-ares intended pharmacological activity receptor kinase domain related subjects suggests dose-proportional pk phase 1b study pre-dose normalized psmad2 kinase inhibitor ly2109761 privacy choices/manage cookies

Questions {❓}

• Nancey S, Boschetti G, Cotte E, Ruel K, Almeras T, Chauvenet M et al (2012) Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab is associated with a profound long-lasting depletion of Foxp3+ regulatory T cells: a mechanistic explanation for ipilimumab-induced severe enterocolitis?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
         description: Purpose Transforming growth factor-beta (TGF-β) signaling plays a key role in epithelial-mesenchymal transition (EMT) of tumors, including malignant glioma. Small molecule inhibitors (SMI) blocking TGF-β signaling reverse EMT and arrest tumor progression. Several SMIs were developed, but currently only LY2157299 monohydrate (galunisertib) was advanced to clinical investigation. Design The first-in-human dose study had three parts (Part A, dose escalation, n = 39; Part B, safety combination with lomustine, n = 26; Part C, relative bioavailability study, n = 14). Results A preclinical pharmacokinetic/pharmacodynamic (PK/PD) model predicted a therapeutic window up to 300 mg/day and was confirmed in Part A after continuous PK/PD. PK was not affected by co-medications such as enzyme-inducing anti-epileptic drugs or proton pump inhibitors. Changes in pSMAD2 levels in peripheral blood mononuclear cells were associated with exposure indicating target-related pharmacological activity of galunisertib. Twelve (12/79; 15 %) patients with refractory/relapsed malignant glioma had durable stable disease (SD) for 6 or more cycles, partial responses (PR), or complete responses (CR). These patients with clinical benefit had high plasma baseline levels of MDC/CCL22 and low protein expression of pSMAD2 in their tumors. Of the 5 patients with IDH1/2 mutation, 4 patients had a clinical benefit as defined by CR/PR and SD ≥6 cycles. Galunisertib had a favorable toxicity profile and no cardiac adverse events. Conclusion Based on the PK, PD, and biomarker evaluations, the intermittent administration of galunisertib at 300 mg/day is safe for future clinical investigation.
         datePublished:2014-12-23T00:00:00Z
         dateModified:2014-12-23T00:00:00Z
         pageStart:357
         pageEnd:370
         sameAs:https://doi.org/10.1007/s10637-014-0192-4
         keywords:
            TGF-β inhibitor
            Galunisertib
            First-in-Human Dose
            Glioma
            Pharmacokinetics
            Pharmacodynamics
            Oncology
            Pharmacology/Toxicology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig5_HTML.gif
         isPartOf:
            name:Investigational New Drugs
            issn:
               1573-0646
               0167-6997
            volumeNumber:33
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jordi Rodón
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.)
                     address:
                        name:Servei d’Oncologia Medica, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Michael Carducci
               affiliation:
                     name:Johns Hopkins Kimmel Cancer Center
                     address:
                        name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Juan M. Sepulveda-Sánchez
               affiliation:
                     name:Hospital Universitario 12 de Octubre
                     address:
                        name:Hospital Universitario 12 de Octubre, Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Analía Azaro
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emiliano Calvo
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
                     name:Centro Integral Oncológico Clara Campal
                     address:
                        name:START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Joan Seoane
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Irene Braña
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elisabet Sicart
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ivelina Gueorguieva
               affiliation:
                     name:Eli Lilly and Company
                     address:
                        name:Eli Lilly and Company, Erl Wood, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ann Cleverly
               affiliation:
                     name:Eli Lilly and Company
                     address:
                        name:Eli Lilly and Company, Erl Wood, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. Sokalingum Pillay
               affiliation:
                     name:Eli Lilly and Company
                     address:
                        name:Eli Lilly and Company, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Durisala Desaiah
               affiliation:
                     name:Eli Lilly and Company
                     address:
                        name:Eli Lilly and Company, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shawn T. Estrem
               affiliation:
                     name:Eli Lilly and Company
                     address:
                        name:Eli Lilly and Company, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luis Paz-Ares
               affiliation:
                     name:Hospital Virgen del Rocío
                     address:
                        name:Hospital Virgen del Rocío, Sevilla, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthias Holdhoff
               affiliation:
                     name:Johns Hopkins Kimmel Cancer Center
                     address:
                        name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jaishri Blakeley
               affiliation:
                     name:Johns Hopkins University
                     address:
                        name:Neurology/Neurosurgery/and Oncology, Johns Hopkins University, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael M. Lahn
               affiliation:
                     name:Eli Lilly and Company
                     address:
                        name:Eli Lilly and Company, Indianapolis, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jose Baselga
               affiliation:
                     name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                     address:
                        name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
      description: Purpose Transforming growth factor-beta (TGF-β) signaling plays a key role in epithelial-mesenchymal transition (EMT) of tumors, including malignant glioma. Small molecule inhibitors (SMI) blocking TGF-β signaling reverse EMT and arrest tumor progression. Several SMIs were developed, but currently only LY2157299 monohydrate (galunisertib) was advanced to clinical investigation. Design The first-in-human dose study had three parts (Part A, dose escalation, n = 39; Part B, safety combination with lomustine, n = 26; Part C, relative bioavailability study, n = 14). Results A preclinical pharmacokinetic/pharmacodynamic (PK/PD) model predicted a therapeutic window up to 300 mg/day and was confirmed in Part A after continuous PK/PD. PK was not affected by co-medications such as enzyme-inducing anti-epileptic drugs or proton pump inhibitors. Changes in pSMAD2 levels in peripheral blood mononuclear cells were associated with exposure indicating target-related pharmacological activity of galunisertib. Twelve (12/79; 15 %) patients with refractory/relapsed malignant glioma had durable stable disease (SD) for 6 or more cycles, partial responses (PR), or complete responses (CR). These patients with clinical benefit had high plasma baseline levels of MDC/CCL22 and low protein expression of pSMAD2 in their tumors. Of the 5 patients with IDH1/2 mutation, 4 patients had a clinical benefit as defined by CR/PR and SD ≥6 cycles. Galunisertib had a favorable toxicity profile and no cardiac adverse events. Conclusion Based on the PK, PD, and biomarker evaluations, the intermittent administration of galunisertib at 300 mg/day is safe for future clinical investigation.
      datePublished:2014-12-23T00:00:00Z
      dateModified:2014-12-23T00:00:00Z
      pageStart:357
      pageEnd:370
      sameAs:https://doi.org/10.1007/s10637-014-0192-4
      keywords:
         TGF-β inhibitor
         Galunisertib
         First-in-Human Dose
         Glioma
         Pharmacokinetics
         Pharmacodynamics
         Oncology
         Pharmacology/Toxicology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10637-014-0192-4/MediaObjects/10637_2014_192_Fig5_HTML.gif
      isPartOf:
         name:Investigational New Drugs
         issn:
            1573-0646
            0167-6997
         volumeNumber:33
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jordi Rodón
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.)
                  address:
                     name:Servei d’Oncologia Medica, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Michael Carducci
            affiliation:
                  name:Johns Hopkins Kimmel Cancer Center
                  address:
                     name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Juan M. Sepulveda-Sánchez
            affiliation:
                  name:Hospital Universitario 12 de Octubre
                  address:
                     name:Hospital Universitario 12 de Octubre, Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Analía Azaro
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emiliano Calvo
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
                  name:Centro Integral Oncológico Clara Campal
                  address:
                     name:START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Joan Seoane
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Irene Braña
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elisabet Sicart
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ivelina Gueorguieva
            affiliation:
                  name:Eli Lilly and Company
                  address:
                     name:Eli Lilly and Company, Erl Wood, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ann Cleverly
            affiliation:
                  name:Eli Lilly and Company
                  address:
                     name:Eli Lilly and Company, Erl Wood, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. Sokalingum Pillay
            affiliation:
                  name:Eli Lilly and Company
                  address:
                     name:Eli Lilly and Company, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Durisala Desaiah
            affiliation:
                  name:Eli Lilly and Company
                  address:
                     name:Eli Lilly and Company, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shawn T. Estrem
            affiliation:
                  name:Eli Lilly and Company
                  address:
                     name:Eli Lilly and Company, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luis Paz-Ares
            affiliation:
                  name:Hospital Virgen del Rocío
                  address:
                     name:Hospital Virgen del Rocío, Sevilla, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthias Holdhoff
            affiliation:
                  name:Johns Hopkins Kimmel Cancer Center
                  address:
                     name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jaishri Blakeley
            affiliation:
                  name:Johns Hopkins University
                  address:
                     name:Neurology/Neurosurgery/and Oncology, Johns Hopkins University, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael M. Lahn
            affiliation:
                  name:Eli Lilly and Company
                  address:
                     name:Eli Lilly and Company, Indianapolis, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jose Baselga
            affiliation:
                  name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
                  address:
                     name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Investigational New Drugs
      issn:
         1573-0646
         0167-6997
      volumeNumber:33
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.)
      address:
         name:Servei d’Oncologia Medica, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
         type:PostalAddress
      name:Johns Hopkins Kimmel Cancer Center
      address:
         name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
         type:PostalAddress
      name:Hospital Universitario 12 de Octubre
      address:
         name:Hospital Universitario 12 de Octubre, Madrid, Spain
         type:PostalAddress
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:Centro Integral Oncológico Clara Campal
      address:
         name:START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain
         type:PostalAddress
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
      name:Eli Lilly and Company
      address:
         name:Eli Lilly and Company, Erl Wood, UK
         type:PostalAddress
      name:Eli Lilly and Company
      address:
         name:Eli Lilly and Company, Erl Wood, UK
         type:PostalAddress
      name:Eli Lilly and Company
      address:
         name:Eli Lilly and Company, Indianapolis, USA
         type:PostalAddress
      name:Eli Lilly and Company
      address:
         name:Eli Lilly and Company, Indianapolis, USA
         type:PostalAddress
      name:Eli Lilly and Company
      address:
         name:Eli Lilly and Company, Indianapolis, USA
         type:PostalAddress
      name:Hospital Virgen del Rocío
      address:
         name:Hospital Virgen del Rocío, Sevilla, Spain
         type:PostalAddress
      name:Johns Hopkins Kimmel Cancer Center
      address:
         name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
         type:PostalAddress
      name:Johns Hopkins University
      address:
         name:Neurology/Neurosurgery/and Oncology, Johns Hopkins University, Baltimore, USA
         type:PostalAddress
      name:Eli Lilly and Company
      address:
         name:Eli Lilly and Company, Indianapolis, USA
         type:PostalAddress
      name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
      address:
         name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jordi Rodón
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.)
            address:
               name:Servei d’Oncologia Medica, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Michael Carducci
      affiliation:
            name:Johns Hopkins Kimmel Cancer Center
            address:
               name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Juan M. Sepulveda-Sánchez
      affiliation:
            name:Hospital Universitario 12 de Octubre
            address:
               name:Hospital Universitario 12 de Octubre, Madrid, Spain
               type:PostalAddress
            type:Organization
      name:Analía Azaro
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Emiliano Calvo
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
            name:Centro Integral Oncológico Clara Campal
            address:
               name:START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain
               type:PostalAddress
            type:Organization
      name:Joan Seoane
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Irene Braña
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Elisabet Sicart
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
      name:Ivelina Gueorguieva
      affiliation:
            name:Eli Lilly and Company
            address:
               name:Eli Lilly and Company, Erl Wood, UK
               type:PostalAddress
            type:Organization
      name:Ann Cleverly
      affiliation:
            name:Eli Lilly and Company
            address:
               name:Eli Lilly and Company, Erl Wood, UK
               type:PostalAddress
            type:Organization
      name:N. Sokalingum Pillay
      affiliation:
            name:Eli Lilly and Company
            address:
               name:Eli Lilly and Company, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Durisala Desaiah
      affiliation:
            name:Eli Lilly and Company
            address:
               name:Eli Lilly and Company, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Shawn T. Estrem
      affiliation:
            name:Eli Lilly and Company
            address:
               name:Eli Lilly and Company, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Luis Paz-Ares
      affiliation:
            name:Hospital Virgen del Rocío
            address:
               name:Hospital Virgen del Rocío, Sevilla, Spain
               type:PostalAddress
            type:Organization
      name:Matthias Holdhoff
      affiliation:
            name:Johns Hopkins Kimmel Cancer Center
            address:
               name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Jaishri Blakeley
      affiliation:
            name:Johns Hopkins University
            address:
               name:Neurology/Neurosurgery/and Oncology, Johns Hopkins University, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:Michael M. Lahn
      affiliation:
            name:Eli Lilly and Company
            address:
               name:Eli Lilly and Company, Indianapolis, USA
               type:PostalAddress
            type:Organization
      name:Jose Baselga
      affiliation:
            name:Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona
            address:
               name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
      name:Servei d’Oncologia Medica, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain
      name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
      name:Hospital Universitario 12 de Octubre, Madrid, Spain
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
      name:START Madrid, Centro Integral Oncológico Clara Campal, Madrid, Spain
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain
      name:Eli Lilly and Company, Erl Wood, UK
      name:Eli Lilly and Company, Erl Wood, UK
      name:Eli Lilly and Company, Indianapolis, USA
      name:Eli Lilly and Company, Indianapolis, USA
      name:Eli Lilly and Company, Indianapolis, USA
      name:Hospital Virgen del Rocío, Sevilla, Spain
      name:Johns Hopkins Kimmel Cancer Center, Baltimore, USA
      name:Neurology/Neurosurgery/and Oncology, Johns Hopkins University, Baltimore, USA
      name:Eli Lilly and Company, Indianapolis, USA
      name:Medical Oncology, Vall d’Hebron University Hospital and Universitat Autonoma de Barcelona, Barcelona, Spain

External Links {🔗}(152)

• What's the income of https://www.springernature.com/gp/authors?
• How much profit does https://link.springernature.com/home/ generate?
• What is the earnings of https://order.springer.com/public/cart?
• How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research bring in each month?
• Monthly income for https://submission.nature.com/new-submission/10637/3
• How much cash flow does https://beta.springernature.com/pre-submission?journalId=10637 have monthly?
• Get to know https://doi.org/10.1073%2Fpnas.78.9.5339's earnings
• What's http://www.ncbi.nlm.nih.gov/pmc/articles/PMC348740's gross income?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6975480 bring in each month?
• How much money does http://scholar.google.com/scholar_lookup?&title=New%20class%20of%20transforming%20growth%20factors%20potentiated%20by%20epidermal%20growth%20factor%3A%20isolation%20from%20non-neoplastic%20tissues&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.78.9.5339&volume=78&pages=5339-5343&publication_year=1981&author=Roberts%2CAB&author=Anzano%2CMA&author=Lamb%2CLC&author=Smith%2CJM&author=Sporn%2CMB make?
• Earnings of https://doi.org/10.1016%2FS0092-8674%2800%2900121-5
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11057902 earning monthly?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=TGFbeta%20signaling%20in%20growth%20control%2C%20cancer%2C%20and%20heritable%20disorders&journal=Cell&doi=10.1016%2FS0092-8674%2800%2900121-5&volume=103&pages=295-309&publication_year=2000&author=Massague%2CJ&author=Blain%2CSW&author=Lo%2CRS?
• Earnings of https://doi.org/10.1158%2F0008-5472.CAN-04-1013
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15520202?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=SD-208%2C%20a%20novel%20transforming%20growth%20factor%20beta%20receptor%20I%20kinase%20inhibitor%2C%20inhibits%20growth%20and%20invasiveness%20and%20enhances%20immunogenicity%20of%20murine%20and%20human%20glioma%20cells%20in%20vitro%20and%20in%20vivo&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-04-1013&volume=64&pages=7954-7961&publication_year=2004&author=Uhl%2CM&author=Aulwurm%2CS&author=Wischhusen%2CJ&author=Weiler%2CM&author=Ma%2CJY&author=Almirez%2CR generate?
• What are the total earnings of https://doi.org/10.1016%2Fj.ccr.2010.10.023?
• Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21156287
• How much profit does http://scholar.google.com/scholar_lookup?&title=TGF-beta%20receptor%20inhibitors%20target%20the%20CD44%28high%29%2FId1%28high%29%20glioma-initiating%20cell%20population%20in%20human%20glioblastoma&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2010.10.023&volume=18&pages=655-668&publication_year=2010&author=Anido%2CJ&author=Saez-Borderias%2CA&author=Gonzalez-Junca%2CA&author=Rodon%2CL&author=Folch%2CG&author=Carmona%2CMA make?
• What's the monthly money flow for https://doi.org/10.1093%2Fneuonc%2Fnoq142?
• How much does http://scholar.google.com/scholar_lookup?&title=Targeted%20therapy%20for%20high-grade%20glioma%20with%20the%20TGF-beta2%20inhibitor%20trabedersen%3A%20results%20of%20a%20randomized%20and%20controlled%20phase%20IIb%20study&journal=Neurol%20Oncol&doi=10.1093%2Fneuonc%2Fnoq142&volume=13&pages=132-142&publication_year=2011&author=Bogdahn%2CU&author=Hau%2CP&author=Stockhammer%2CG&author=Venkataramana%2CNK&author=Mahapatra%2CAK&author=Suri%2CA net monthly?
• What's the total monthly financial gain of https://doi.org/10.1021%2Fjm0205705?
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12954047?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Synthesis%20and%20activity%20of%20new%20aryl-%20and%20heteroaryl-substituted%20pyrazole%20inhibitors%20of%20the%20transforming%20growth%20factor-beta%20type%20I%20receptor%20kinase%20domain&journal=J%20Med%20Chem&doi=10.1021%2Fjm0205705&volume=46&pages=3953-3956&publication_year=2003&author=Sawyer%2CJS&author=Anderson%2CBD&author=Beight%2CDW&author=Campbell%2CRM&author=Jones%2CML&author=Herron%2CDK
• How much does https://doi.org/10.1111%2Fbcp.12256 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24868575 gross monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Defining%20a%20therapeutic%20window%20for%20the%20novel%20TGF-%CE%B2%20inhibitor%20GALUNISERTIB%20monohydrate%20based%20on%20a%20pharmacokinetic%2Fpharmacodynamic%20model&journal=Br%20J%20Clin%20Pharmacol&doi=10.1111%2Fbcp.12256&volume=77&pages=796-807&publication_year=2014&author=Gueorguieva%2CI&author=Cleverly%2CAL&author=Stauber%2CA&author=Pillay%2CNS&author=Rodon%2CJA&author=Miles%2CCP earn?
• What is the monthly revenue of https://doi.org/10.1080%2F13547500601162441?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17453744?
• How much does http://scholar.google.com/scholar_lookup?&title=Development%20and%20validation%20of%20a%20phosphorylated%20SMAD%20ex%20vivo%20stimulation%20assay&journal=Biomarkers&doi=10.1080%2F13547500601162441&volume=12&pages=313-330&publication_year=2007&author=Farrington%2CDL&author=Yingling%2CJM&author=Fill%2CJA&author=Yan%2CL&author=Qian%2CYW&author=Shou%2CJ pull in monthly?
• What's https://doi.org/10.1080%2F13547500701676019's gross income?
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18270872
• How much income is http://scholar.google.com/scholar_lookup?&title=TGF-beta%20signalling-related%20markers%20in%20cancer%20patients%20with%20bone%20metastasis&journal=Biomarkers&doi=10.1080%2F13547500701676019&volume=13&pages=217-236&publication_year=2008&author=Baselga%2CJ&author=Rothenberg%2CML&author=Tabernero%2CJ&author=Seoane%2CJ&author=Daly%2CT&author=Cleverly%2CA earning monthly?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2358840?
• How much does http://scholar.google.com/scholar_lookup?&title=Response%20criteria%20for%20phase%20II%20studies%20of%20supratentorial%20malignant%20glioma&journal=J%20Clin%20Oncol&volume=8&pages=1277-1280&publication_year=1990&author=Macdonald%2CDR&author=Cascino%2CTL&author=Schold%2CSC&author=Cairncross%2CJG pull in?
• How much money does https://doi.org/10.2174%2F157488408785747656 generate?
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2748699?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18781906 gross monthly?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Influence%20of%20enzyme-inducing%20antiepileptic%20drugs%20on%20trough%20level%20of%20Imatinib%20in%20glioblastoma%20patients&journal=Curr%20Clin%20Pharmacol&doi=10.2174%2F157488408785747656&volume=3&pages=198-203&publication_year=2008&author=Pursche%2CS&author=Schleyer%2CE&author=Bonin%2CM&author=Ehninger%2CG&author=Said%2CSM&author=Prondzinsky%2CR
• https://doi.org/10.1038%2Fnbt.2696 income
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Development%20and%20validation%20of%20a%20clinical%20cancer%20genomic%20profiling%20test%20based%20on%20massively%20parallel%20DNA%20sequencing&journal=Nature%20Biotechnol&doi=10.1038%2Fnbt.2696&volume=31&pages=1023-1031&publication_year=2013&author=Frampton%2CGM&author=Fichtenholtz%2CA&author=Otto%2CGA&author=Wang%2CK&author=Downing%2CSR&author=He%2CJ
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21465149
• How much does http://scholar.google.com/scholar_lookup?&title=Genomic%20profiles%20of%20glioma&journal=Curr%20Neurol%20Neurosci%20Rep&doi=10.1007%2Fs11910-011-0198-7&volume=11&pages=291-297&publication_year=2011&author=Brennan%2CC pull in monthly?
• How much does https://doi.org/10.1126%2Fscience.1164382 pull in monthly?
• Income figures for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820389
• What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18772396 each month?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=An%20integrated%20genomic%20analysis%20of%20human%20glioblastoma%20multiforme&journal=Science&doi=10.1126%2Fscience.1164382&volume=321&pages=1807-1812&publication_year=2008&author=Parsons%2CDW&author=Jones%2CS&author=Zhang%2CX&author=Lin%2CJC&author=Leary%2CRJ&author=Angenendt%2CP
• https://doi.org/10.1038%2Fnature11323's financial summary
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005896?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22763442 make?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=IDH1%28R132H%29%20mutation%20increases%20murine%20haematopoietic%20progenitors%20and%20alters%20epigenetics&journal=Nature&doi=10.1038%2Fnature11323&volume=488&pages=656-659&publication_year=2012&author=Sasaki%2CM&author=Knobbe%2CCB&author=Munger%2CJC&author=Lind%2CEF&author=Brenner%2CD&author=Brustle%2CA?
• How much revenue does https://doi.org/10.1016%2Fj.ccr.2009.12.020 generate?
• What's the financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818769?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20129251 pull in monthly?
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Integrated%20genomic%20analysis%20identifies%20clinically%20relevant%20subtypes%20of%20glioblastoma%20characterized%20by%20abnormalities%20in%20PDGFRA%2C%20IDH1%2C%20EGFR%2C%20and%20NF1&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2009.12.020&volume=17&pages=98-110&publication_year=2010&author=Verhaak%2CRG&author=Hoadley%2CKA&author=Purdom%2CE&author=Wang%2CV&author=Qi%2CY&author=Wilkerson%2CMD
• How much profit does https://doi.org/10.1097%2FFPC.0b013e328335731c generate?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20084050
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Application%20of%20T%20cell-based%20transcriptomics%20to%20identify%20three%20candidate%20biomarkers%20for%20monitoring%20anti-TGFbetaR%20therapy&journal=Pharmacogenet%20Genomics&doi=10.1097%2FFPC.0b013e328335731c&volume=20&pages=147-156&publication_year=2010&author=Classen%2CS&author=Muth%2CC&author=Debey-Pascher%2CS&author=Eggle%2CD&author=Beyer%2CM&author=Mallmann%2CMR
• How much revenue does https://doi.org/10.1093%2Fjmcb%2Fmjr033 generate?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22158907?
• How much does http://scholar.google.com/scholar_lookup?&title=TGF-beta%3A%20the%20sword%2C%20the%20wand%2C%20and%20the%20shield%20of%20FOXP3%28%2B%29%20regulatory%20T%20cells&journal=J%20Mol%20Cell%20Biol&doi=10.1093%2Fjmcb%2Fmjr033&volume=4&pages=29-37&publication_year=2012&author=Tran%2CDQ make?
• How much does https://doi.org/10.1002%2Fibd.21927 net monthly?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22069060's gross income?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Blockade%20of%20cytotoxic%20T-lymphocyte%20antigen-4%20by%20ipilimumab%20is%20associated%20with%20a%20profound%20long-lasting%20depletion%20of%20Foxp3%2B%20regulatory%20T%20cells%3A%20a%20mechanistic%20explanation%20for%20ipilimumab-induced%20severe%20enterocolitis%3F&journal=Inflamm%20Bowel%20Dis&doi=10.1002%2Fibd.21927&volume=18&pages=E1598-E1600&publication_year=2012&author=Nancey%2CS&author=Boschetti%2CG&author=Cotte%2CE&author=Ruel%2CK&author=Almeras%2CT&author=Chauvenet%2CM?
• Learn how profitable https://doi.org/10.1093%2Fneuonc%2Fnos014 is on a monthly basis
• How much does http://scholar.google.com/scholar_lookup?&title=Soluble%20factors%20secreted%20by%20glioblastoma%20cell%20lines%20facilitate%20recruitment%2C%20survival%2C%20and%20expansion%20of%20regulatory%20T%20cells%3A%20implications%20for%20immunotherapy&journal=Neurol%20Oncol&doi=10.1093%2Fneuonc%2Fnos014&volume=14&pages=584-595&publication_year=2012&author=Crane%2CCA&author=Ahn%2CBJ&author=Han%2CSJ&author=Parsa%2CAT earn?
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18505050 making per month?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20regulatory%20T%20cells%20in%20malignant%20glioma&journal=Anticancer%20Res&volume=28&pages=1143-1150&publication_year=2008&author=Sonabend%2CAM&author=Rolle%2CCE&author=Lesniak%2CMS?
• What's the profit of https://doi.org/10.1215%2F15228517-2008-106?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Lactate%20promotes%20glioma%20migration%20by%20TGF-beta2-dependent%20regulation%20of%20matrix%20metalloproteinase-2&journal=Neurol%20Oncol&doi=10.1215%2F15228517-2008-106&volume=11&pages=368-380&publication_year=2009&author=Baumann%2CF&author=Leukel%2CP&author=Doerfelt%2CA&author=Beier%2CCP&author=Dettmer%2CK&author=Oefner%2CPJ?
• What are the earnings of https://doi.org/10.1158%2F1055-9965.EPI-09-1077?
• How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20530493 making per month?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Identification%20of%20potential%20serum%20biomarkers%20of%20glioblastoma%3A%20serum%20osteopontin%20levels%20correlate%20with%20poor%20prognosis&journal=Cancer%20Epidemiol%20Biomarkers%20Prev&doi=10.1158%2F1055-9965.EPI-09-1077&volume=19&pages=1409-1422&publication_year=2010&author=Sreekanthreddy%2CP&author=Srinivasan%2CH&author=Kumar%2CDM&author=Nijaguna%2CMB&author=Sridevi%2CS&author=Vrinda%2CM generate?
• Financial intake of https://doi.org/10.1155%2F2011%2F716301
• How much money does http://scholar.google.com/scholar_lookup?&title=Pro-%20and%20anti-inflammatory%20cytokines%20during%20immune%20stimulation%3A%20modulation%20of%20iron%20status%20and%20red%20blood%20cell%20profile&journal=Mediat%20Inflamm&doi=10.1155%2F2011%2F716301&volume=2011&publication_year=2011&author=Koorts%2CAM&author=Levay%2CPF&author=Becker%2CPJ&author=Viljoen%2CM make?
• Financial intake of https://doi.org/10.1215%2FS1152851704001061
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20interleukin-8%20and%20its%20receptors%20in%20gliomagenesis%20and%20tumoral%20angiogenesis&journal=Neurol%20Oncol&doi=10.1215%2FS1152851704001061&volume=7&pages=122-133&publication_year=2005&author=Brat%2CDJ&author=Bellail%2CAC&author=Meir%2CEG?
• What's the monthly money flow for https://doi.org/10.1038%2Fnrclinonc.2009.63?
• Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057433's earnings
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19483739 bring in each month?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Biomarkers%20of%20response%20and%20resistance%20to%20antiangiogenic%20therapy&journal=Nat%20Rev%20Clin%20Oncol&doi=10.1038%2Fnrclinonc.2009.63&volume=6&pages=327-338&publication_year=2009&author=Jain%2CRK&author=Duda%2CDG&author=Willett%2CCG&author=Sahani%2CDV&author=Zhu%2CAX&author=Loeffler%2CJS?
• Monthly income for https://doi.org/10.1016%2Fj.ccr.2006.11.023
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17292826 generate?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=High%20TGFbeta-Smad%20activity%20confers%20poor%20prognosis%20in%20glioma%20patients%20and%20promotes%20cell%20proliferation%20depending%20on%20the%20methylation%20of%20the%20PDGF-B%20gene&journal=Cancer%20Cell&doi=10.1016%2Fj.ccr.2006.11.023&volume=11&pages=147-160&publication_year=2007&author=Bruna%2CA&author=Darken%2CRS&author=Rojo%2CF&author=Ocana%2CA&author=Penuelas%2CS&author=Arias%2CA?
• What's the financial intake of https://doi.org/10.1159%2F000332849?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21985798 pull in monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=VEGFR2%20expression%20and%20TGF-beta%20signaling%20in%20initial%20and%20recurrent%20high-grade%20human%20glioma&journal=Oncology&doi=10.1159%2F000332849&volume=81&pages=126-134&publication_year=2011&author=Kuczynski%2CEA&author=Patten%2CSG&author=Coomber%2CBL gross monthly?
• https://doi.org/10.1016%2FS0002-9440%2810%2963463-3 income
• Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868272
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12937144 generate monthly?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20gene%20expression%20profiles%20associated%20with%20glioma%20progression%20using%20oligonucleotide-based%20microarray%20analysis%20and%20real-time%20reverse%20transcription-polymerase%20chain%20reaction&journal=Am%20J%20Pathol&doi=10.1016%2FS0002-9440%2810%2963463-3&volume=163&pages=1033-1043&publication_year=2003&author=Boom%2CJ&author=Wolter%2CM&author=Kuick%2CR&author=Misek%2CDE&author=Youkilis%2CAS&author=Wechsler%2CDS generate?
• Find out how much https://doi.org/10.1158%2F1078-0432.CCR-11-2855 earns monthly
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22547771 have?
• How profitable is http://scholar.google.com/scholar_lookup?&title=LY2109761%20attenuates%20radiation-induced%20pulmonary%20murine%20fibrosis%20via%20reversal%20of%20TGF-beta%20and%20BMP-associated%20proinflammatory%20and%20proangiogenic%20signals&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-11-2855&volume=18&pages=3616-3627&publication_year=2012&author=Flechsig%2CP&author=Dadrich%2CM&author=Bickelhaupt%2CS&author=Jenne%2CJ&author=Hauser%2CK&author=Timke%2CC?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114247 make?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21677877's gross income?
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Trimodal%20glioblastoma%20treatment%20consisting%20of%20concurrent%20radiotherapy%2C%20temozolomide%2C%20and%20the%20novel%20TGF-beta%20receptor%20I%20kinase%20inhibitor%20LY2109761&journal=Neoplasia&volume=13&pages=537-549&publication_year=2011&author=Zhang%2CM&author=Herion%2CTW&author=Timke%2CC&author=Han%2CN&author=Hauser%2CK&author=Weber%2CKJ?
• Explore the financials of https://citation-needed.springer.com/v2/references/10.1007/s10637-014-0192-4?format=refman&flavour=references
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jordi%20Rod%C3%B3n?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jordi%20Rod%C3%B3n%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20Carducci make?
• What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20Carducci%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Juan%20M.%20Sepulveda-S%C3%A1nchez?
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Juan%20M.%20Sepulveda-S%C3%A1nchez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Anal%C3%ADa%20Azaro
• Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Anal%C3%ADa%20Azaro%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Emiliano%20Calvo bring in?
• How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Emiliano%20Calvo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Joan%20Seoane
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Joan%20Seoane%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Irene%20Bra%C3%B1a pull in monthly?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Irene%20Bra%C3%B1a%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elisabet%20Sicart's earnings
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elisabet%20Sicart%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ivelina%20Gueorguieva
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ivelina%20Gueorguieva%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ann%20Cleverly make?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ann%20Cleverly%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Sokalingum%20Pillay's revenue stream
• Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Sokalingum%20Pillay%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Durisala%20Desaiah bring in each month?
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Durisala%20Desaiah%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shawn%20T.%20Estrem?
• What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shawn%20T.%20Estrem%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luis%20Paz-Ares rake in every month?
• How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luis%20Paz-Ares%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Matthias%20Holdhoff?
• Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Matthias%20Holdhoff%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jaishri%20Blakeley's gross income?
• How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jaishri%20Blakeley%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Michael%20M.%20Lahn is on a monthly basis
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Michael%20M.%20Lahn%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jose%20Baselga
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jose%20Baselga%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• What is the earnings of https://s100.copyright.com/AppDispatchServlet?title=Pharmacokinetic%2C%20pharmacodynamic%20and%20biomarker%20evaluation%20of%20transforming%20growth%20factor-%CE%B2%20receptor%20I%20kinase%20inhibitor%2C%20galunisertib%2C%20in%20phase%201%20study%20in%20patients%20with%20advanced%20cancer&author=Jordi%20Rod%C3%B3n%20et%20al&contentID=10.1007%2Fs10637-014-0192-4©right=The%20Author%28s%29&publication=0167-6997&publicationDate=2014-12-23&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY?
• What's the monthly money flow for https://crossmark.crossref.org/dialog/?doi=10.1007/s10637-014-0192-4?
• What's the financial outcome of https://citation-needed.springer.com/v2/references/10.1007/s10637-014-0192-4?format=refman&flavour=citation?
• Explore the financials of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
• Discover the revenue of https://www.springernature.com/gp/products
• What's the financial gain of https://www.springernature.com/gp/librarians?
• How much does https://www.springernature.com/gp/societies rake in every month?
• What's the financial gain of https://www.springernature.com/gp/partners?
• What's the profit of https://www.springer.com/?
• Explore the financials of https://www.nature.com/
• How much does https://www.biomedcentral.com/ pull in monthly?
• How much does https://www.palgrave.com/ gross monthly?
• How much does https://www.apress.com/ generate monthly?
• What's the total monthly financial gain of https://www.springernature.com/gp/legal/ccpa?
• How profitable is https://www.springernature.com/gp/info/accessibility?
• What's the profit of https://support.springernature.com/en/support/home?
• Financial intake of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• How much does https://www.springernature.com/ pull in?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref